Panacea Life Sciences Holdings annual revenue
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Revenue Growth & History (PLSH)
Panacea Life Sciences Holdings reported $2.4M in revenue for fiscal 2023, an increase of 46.59% from the previous fiscal year.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $2.4M | $757,978 | +46.59% |
| 2022 | 2022-12-31 | $1.6M | −$432,649 | −21.01% |
| 2021 | 2021-12-31 | $2.1M | −$7.0M | −77.16% |
| 2020 | 2020-12-31 | $9.0M | $8.7M | +2508.69% |
| 2019 | 2019-12-31 | $345,680 | $345,680 | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | −$213 | −100.00% |
| 2015 | 2015-12-31 | $213 | −$639 | −75.00% |
| 2014 | 2014-12-31 | $852 | — | — |
Panacea Life Sciences Holdings quarterly revenue
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $49,767 | — | — |
| Q2 2025 | 2025-06-30 | $215,129 | — | — |
| Q1 2025 | 2025-03-31 | $595,883 | −$460,564 | −43.60% |
| Q1 2024 | 2024-03-31 | $1.1M | $378,966 | +55.94% |
| Q4 2023 | 2023-12-31 | $960,496 | $635,708 | +195.73% |
| Q3 2023 | 2023-09-30 | $347,851 | −$18,393 | −5.02% |
| Q2 2023 | 2023-06-30 | $399,128 | −$70,344 | −14.98% |
| Q1 2023 | 2023-03-31 | $677,481 | $211,007 | +45.23% |
| Q4 2022 | 2022-12-31 | $324,788 | −$833,303 | −71.95% |
| Q3 2022 | 2022-09-30 | $366,244 | −$221,796 | −37.72% |
| Q2 2022 | 2022-06-30 | $469,472 | $155,976 | +49.75% |
| Q1 2022 | 2022-03-31 | $466,474 | $466,474 | — |
| Q4 2021 | 2021-12-31 | $1.2M | $481,480 | +71.16% |
| Q3 2021 | 2021-09-30 | $588,040 | −$755,601 | −56.24% |
| Q2 2021 | 2021-06-30 | $313,496 | −$5.8M | −94.91% |
| Q1 2021 | 2021-03-31 | $0 | −$836,000 | −100.00% |
| Q4 2020 | 2020-12-31 | $676,611 | $506,228 | +297.11% |
| Q3 2020 | 2020-09-30 | $1.3M | $1.3M | +2133.71% |
| Q2 2020 | 2020-06-30 | $6.2M | $6.1M | +6113.41% |
| Q1 2020 | 2020-03-31 | $836,000 | $820,020 | +5131.54% |
| Q4 2019 | 2019-12-31 | $170,383 | $170,383 | — |
| Q3 2019 | 2019-09-30 | $60,153 | $60,153 | — |
| Q2 2019 | 2019-06-30 | $99,164 | $99,164 | — |
| Q1 2019 | 2019-03-31 | $15,980 | $15,980 | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | $0 | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | −$213 | −100.00% |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $213 | — | — |
| Q3 2015 | 2015-09-30 | $0 | −$213 | −100.00% |
| Q2 2015 | 2015-06-30 | $0 | −$213 | −100.00% |
| Q1 2015 | 2015-03-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $213 | — | — |
| Q2 2014 | 2014-06-30 | $213 | — | — |
Panacea Life Sciences Holdings revenue growth trends
Panacea Life Sciences Holdings's latest reported quarter, Q3 2025, generated $49,767 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Panacea Life Sciences Holdings source filings ↗